Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
US Army
Fish and Richardson
Harvard Business School
Chubb
Deloitte
Daiichi Sankyo
Federal Trade Commission
Cerilliant
McKinsey

Generated: January 17, 2018

DrugPatentWatch Database Preview

ZYRTEC Drug Profile

« Back to Dashboard

When do Zyrtec patents expire, and what generic alternatives are available?

Zyrtec is a drug marketed by J And J Consumer Inc and is included in four NDAs. There are three patents protecting this drug and three Paragraph IV challenges.

The generic ingredient in ZYRTEC is cetirizine hydrochloride; pseudoephedrine hydrochloride. There are thirty-nine drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride; pseudoephedrine hydrochloride profile page.

US Patents and Regulatory Information for ZYRTEC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer Inc ZYRTEC cetirizine hydrochloride SYRUP;ORAL 020346-001 Sep 27, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
J And J Consumer Inc ZYRTEC-D 12 HOUR cetirizine hydrochloride; pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 021150-002 Nov 9, 2007 OTC Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
J And J Consumer Inc ZYRTEC ALLERGY cetirizine hydrochloride TABLET;ORAL 019835-004 Nov 16, 2007 OTC Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
J And J Consumer Inc ZYRTEC-D 12 HOUR cetirizine hydrochloride; pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 021150-002 Nov 9, 2007 OTC Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
J And J Consumer Inc ZYRTEC ALLERGY cetirizine hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 022578-001 Sep 3, 2010 OTC Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
J And J Consumer Inc ZYRTEC ALLERGY cetirizine hydrochloride TABLET;ORAL 019835-003 Nov 16, 2007 OTC Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
J And J Consumer Inc ZYRTEC HIVES RELIEF cetirizine hydrochloride TABLET;ORAL 019835-006 Nov 16, 2007 OTC Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
J And J Consumer Inc ZYRTEC HIVES RELIEF cetirizine hydrochloride TABLET;ORAL 019835-005 Nov 16, 2007 OTC Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
J And J Consumer Inc ZYRTEC-D 12 HOUR cetirizine hydrochloride; pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 021150-002 Nov 9, 2007 OTC Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for ZYRTEC
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Syrup 5 mg/5 mL ➤ Subscribe 3/19/2007
➤ Subscribe Chewable Tablets 5 mg and 10 mg ➤ Subscribe 3/25/2005
➤ Subscribe Extended-release Tablets 5 mg/120 mg ➤ Subscribe 6/2/2004

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Boehringer Ingelheim
Healthtrust
Medtronic
QuintilesIMS
Express Scripts
US Army
Cantor Fitzgerald
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot